Randomised, double-blinded, placebo-controlled, clinical trial of ozone therapy as treatment of sudden sensorineural hearing loss.
D000328:Adult; D001804:Blood Transfusion, Autologous / Q000379:methods*; D004311:Double-Blind Method; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000628:therapy*; D003639:Hearing Loss, Sudden / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010126:Ozone / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D020127:Recovery of Function; D012720:Severity of Illness Index; D013223:Statistics as Topic; D016896:Treatment Outcome; D055815:Young Adult
D010126:Ozone